COVID-19 progression and convalescence in common variable immunodeficiency patients show dysregulated adaptive immune responses and persistent type I interferon and inflammasome activation.
Rodríguez-Ubreva J, Calafell-Segura J, Calvillo CL, Keller B, Ciudad L, Handfield LF, de la Calle-Fabregat C, Godoy-Tena G, Andrés-León E, Hoo R, Porter T, Prigmore E, Hofmann M, Decker A, Martín J, Vento-Tormo R, Warnatz K, Ballestar E.
Rodríguez-Ubreva J, et al. Among authors: decker a.
Nat Commun. 2024 Nov 28;15(1):10344. doi: 10.1038/s41467-024-54732-x.
Nat Commun. 2024.
PMID: 39609471
Free PMC article.